Title Protocol ID Number
| Phase I Pilot Study of a Multiantigen Loaded Dendretic Cell Vaccine in Patients With Advanced Renal Cell Carcinoma | NCI-G00-1675 |
| Phase I/II Study of Iodine 131 Chimeric Monoclonal Antibody G250 (131I MOAB cG250) in Patients With Advanced Renal Cell Carcinoma | NCI-H97-0004 |
| Phase II Pilot Study of Interleukin-2 and Interferon alpha in Metastatic Renal Cell Carcinoma | NCI-V96-1039 |
| Phase II Study of Adjuvant Autolymphocyte Therapy for Nonmetastatic Renal Cell Carcinoma | NCI-V94-0514 |
| Phase II Study of IFN-A/IL-2/TIL for Metastatic Cancer | NCI-V96-0835 |
| Phase I/II Study of Tretinoin Liposome and Interferon Alpha-2b in Patients with Advanced Renal Cell Carcinoma | NCI-V98-1490 |
| Phase II Adjuvant Study of Interleukin-2 Patients with Stage III or IV Renal Cancer | NCI-V98-1482 |
| Phase III Randomized Study of Radical vs. Kidney Sparing Surgery for Patients with Resectable Renal Cell Cancer | EORTC-30904 |
| Phase I Study of In Vitro-Expanded and Genetically Engineered Bulk, CD8+, and CD4+ TIL and Bulk CD8+, and CD4+ PBL in Combination with IL-2 Alone or IL-2/IFN-A in Patients with Metastatic Melanoma and Renal Cell Carcinoma | NCI-T92-0073D |
| Phase I Pilot Study of Interferon gamma Transduced Autologous Tumor Cell Vaccine for Metastatic Renal Cell Carcinoma | NCI-V95-0648 |
| Phase I Pilot Study of Immunization with Allogenic HLA-A2 Matched Renal Cell Carcinoma Cells Transduced with a Gene for IL-2 in Patients with Advanced Renal Cell Carcinoma | NCI-V92-0050 |
| Phase I Study of Green Tea Extract in Adults with Advanced Solid Tumors | NCI-G98-1375 |